Global Academy for Medical Education

Conferences Earn CME/CE

September 22 - 24, 2022 • Hybrid Event

October 26 - 29 • Hybrid Event

January 28 - February 4, 2023 • Virtual Event

February 19 - 24, 2023 • In-Person Event

There are no results under this Specialty.

There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.

Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma.

“Prevention is low cost, low risk, and effective.”